Jump to the top of the page

Insights

Statistical analysis and insight into activity and trends in M&A and capital markets.

Close up of people looking at some papers

Recent Investment Banking Insights

  • Exit Strategy: Preparing Yourself

    Preparing yourself and your family can be one of the most overlooked parts of an exit strategy. But it goes beyond maximizing tax efficiency and unlocking newfound wealth—it’s a monumental transition filled with emotional considerations.

    Read more

  • Leveraged Finance Newsletter—Unmasking M&A Activity

    Left for dead for nearly two years, the M&A leveraged loan market came back to life in the third quarter, with the Fed’s first interest rate cut in years opening the door for a wave of activity.

    Read more

  • Exit Strategy: Preparing Your Company

    Company leaders who have spent their lives running a business probably have limited experience when it comes to selling one. That means preparation is a crucial part of any effective exit strategy.

    Read more

  • Momentum Continues for Secondaries—With Record Year in Sight

    Improving LP-led pricing, continuing adoption by both GPs and LPs, and a growing supply of capital has the secondary market poised for a full rebound—and possibly record volumes—by year-end.

    Read more

  • The Quarterly Rx: Q3 2024 U.S. Biopharma Recap

    The biopharma sector got a much-needed shot in the arm with the Federal Reserve’s highly anticipated rate cut in September, the first since March 2020.

    Read more

  • Liquidity Options Without Giving Up Control of Your Business

    For leaders of founder-owned businesses, raising significant capital without relinquishing control can seem challenging. But investors focused on non-control transactions are becoming more common—creating opportunities to support growth, strategic acquisitions, and personal liquidity.

    Read more

  • Aviation Services Industry Update

    General aviation activity grew 2% in the second quarter while commercial Revenue Passenger-Kilometer and Available Seat-Kilometer rose in June as the broader market demonstrated its resilience despite macroeconomic pressures.

    Read more

  • Lenders Eyeing Opportunistic Transactions; Borrowers Should Take Note

    A strong rebound in U.S. leveraged loan volume has lenders pivoting to opportunistic transactions—meaning that now is a great time for borrowers to consider refinancing existing debt or returning capital to shareholders.

    Read more

  • Navigating Financial, Strategic, and Quasi-Strategic Buyers

    Certain buyer behaviors remain constant, regardless of economic cycle. In the run-up to a liquidity event, it’s critical to understand the behaviors as they relate to three main buyer categories—financial, strategic, and quasi-strategic.

    Watch the video

  • Refinancings Headline at ‘Loan-a-Palooza’

    After a hot start to the year, the leveraged loan market sparked a heat wave just in time for summer with volumes climbing to near-record levels.

    Read more

  • The Quarterly Rx: Q2 2024 U.S. Biopharma Recap

    After a strong start to the year, the biopharma sector faced renewed headwinds in Q2 2024 including a more hawkish outlook from the Federal Reserve.

    Read more
See more insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures